EpiCept Corporation Announces Pricing of Public Offering

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News:

EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today the pricing of a public offering of 2 million shares of its common stock at $.25 per share and five-year warrants to purchase up to 2 million shares of common stock at an exercise price of $.39 per share. EpiCept will receive approximately $0.5 million in net proceeds from the offering. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM) acted as the exclusive placement agent for the offering. EpiCept intends to use the net proceeds it receives to meet working capital needs and general corporate purposes.

Back to news